Health Insurance Changes and the Breast Cancer Community
Recent federal legislation about health insurance coverage will impact the breast cancer community. Monica Bryant of Triage Cancer talks to us about changes to private insurance (through the ACA healthcare exchange marketplace) and publicly funded insurance including Medicare and Medicaid. We also discuss some of the potential ripple effects, including on cancer screening programs, that may impact the ability of many in the cancer community to access healthcare.
Biosimilars and Their Use in Cancer Treatment
On today's episode, we are thrilled to discuss an important and often misunderstood area of oncology- biosimilars and their increasing use in cancer care. You might be curious, what exactly are biosimilars? How are they developed and approved? And most importantly, how are they transforming the lives of patients diagnosed with cancer? We will break down these questions and more as we explore this with an overview from Dr. Julie Gralow, a breast medical oncologist and chief medical officer at the American Society of Clinical Oncology.